Physicians

Department / Division
Medicine / General Internal Medicine

Address
DUMC 3228
Durham, NC 27710

Appointment Telephone
919-490-9800

Office Telephone
919-490-9800

Fax Telephone
919-419-6218

Training

• MD, University of Pittsburgh School of Medicine (Pennsylvania), 1992

Residency

• Internal Medicine, Allegheny General Hospital (Pennsylvania), 1992-1995

Other Training

• Fellow, American College of Physicians
• Certified Diabetes Educator

Clinical Interests
Diabetes, men's health, computers in medicine

Research Interests
Leadership Positions:

Chief of Clinical Services, Division of General Internal Medicine
Medical Director, Duke Health Center at Pickett Road


Professional Committee Assignments:

Pharmacy and Therapeutics Committee, Duke Hospital
Primary Care Management Committee, Private Diagnostics Clinics
Interdisciplinary Medical Decision Making Initiative, Duke School of Medicine and Duke Fuqua School of Business
Physician Advisory Group, Duke Prospective Health, PrimaHealth IPA
North Carolina Diabetes Advisory Council, North Carolina Department of Health and Human Services, Division of Public Health


Clinical/Research Interest:

Management of Type 2 Diabetes
Management of Hypertension
Management of Chronic Kidney Disease
Quality Improvement/Pay-for-Performance
Medical Practice Management

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• Boehringer Ingelheim
• Consensus Medical Communications
• DIME
• International Medical Press
• Lilly (Eli Lilly)
• M/C Communication
• Society of General Internal Medicine
• Vindico

Representative Publications
Taulien CA, Joy SV. Ruboxistaurin.  Drugs Today (Barc).  2006 Sep;42(9):577-85. (2006) Abstract

Joy SV, Rodgers PT, Scates AC. Incretin mimetics as emerging treatments for type 2 diabetes.  Ann Pharmacother.  2005 Jan;39(1):110-8. (2005) Abstract

Joy SV, Scates AC, Bearelly S, Dar M, Taulien CA, Goebel JA, Cooney MJ. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.  Ann Pharmacother.  2005 Oct;39(10):1693-9. (2005) Abstract

Joy, SV, Gouveia-Pisano, JA, Diaz, S.  An Experience in Creating an Electronic Men’s Health Registry in a Primary Care Setting.  JCOM, Vol 11, (4), 223-228, April 2004 (2004)